CMD Bioscience
New Haven, Connecticut, United States
About CMD Bioscience
CMD Bioscience LLC, a computational biotechnology company, develops a suite of molecular software applications for pharmaceutical, biotech, and life science companies. The company specializes in the peptide drug discovery and research projects. It offers CMDInventusSM, a computational platform for the computer-aided analysis protein-protein interactions (PPIs); analyzing, modeling, and optimizing protein and peptide structures; predicting the water-membrane partitioning behavior of peptides and proteins; and creating peptide therapeutics. The company also develops custom computational peptide discovery solutions, which include computer-enabled macromolecular target modeling and analysis, peptide-based hit identification, and peptide-based hit-to-lead optimization. CMD Bioscience LLC was founded in 2006 and is based in New Haven, Connecticut.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $10K – $50K
- Total funding: $925.0K
- Last round: Series Unknown (Dec 2012)
- Website: cmdbioscience.com
- Phone: 203-298-4251
Industries & Categories
Biopharma, Biotechnology, Life Science
Social Profiles
Canonical: https://fsome.com/organization/cmd-bioscience-2580844 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.